NCT06813287

Brain Monitoring, tDCS and Robotic Training in SCI

Completed Phase 2 Last updated 6 February 2025

What this trial tests

Phase 2 trial testing Electroencephalography (EEG) in Spinal Cord Injuries in 17 participants. Completed in 27 June 2018.

Timeline

1 November 2012

Primary endpoint
31 December 2014

27 June 2018

Quick facts

Lead sponsor	Kathleen Friel
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	17
Start date	1 November 2012
Primary completion	31 December 2014
Estimated completion	27 June 2018
Sites	1 location across United States

Drugs / interventions tested

• Electroencephalography (EEG)
• Upper extremity robot

Conditions studied

• Spinal Cord Injuries — all drugs for Spinal Cord Injuries →

Sponsor

Kathleen Friel

Who can join

Adults 16 to 65, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore the neurophysiological and electroencephalography (EEG) changes that one single session of tDCS and robotics has in the SCI population (Study 1); and to investigate upper limb motor recovery in chronic tetraplegia SCI patients, comparing two rehabilitation strategies: real or sham tDCS combined with upper-limb robotic therapy (Study 2), as well as to characterize the neurophysiological (TMS) and brain signaling (EEG) profile of patients and specific muscles that respond to the combination of neuromodulation and robotic motor training.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.